Effects of Cardiac Telerehabilitation During COVID-19 on Cardiorespiratory Capacities in Coronary Artery Disease Patients.
1 other identifier
observational
54
1 country
1
Brief Summary
After an acute coronary syndrome, an adapted cardiac rehabilitation program is necessary to restore or increase physical capacities and decrease cardiovascular risk. This multidisciplinary care combines physical training sessions and therapeutic education workshops. The COVID-19 pandemic imposed restrictions such as the closure of rehabilitation centres. To remedy this problem, one solution was to adapt the existing program to a remote cardiac telerehabilitation, i.e., medical and paramedical supervision of rehabilitation sessions and therapeutic patient education meetings via digital tools. Recent studies have shown that it was a safe (no reported adverse effects), effective (similar gains in peak oxygen consumption compared to traditional cardiac rehabilitation and patient-adherence alternative.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedFirst Submitted
Initial submission to the registry
February 27, 2023
CompletedFirst Posted
Study publicly available on registry
March 1, 2023
CompletedMarch 3, 2023
December 1, 2021
9 months
February 27, 2023
March 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline oxygen (VO2) (ml/min/kg) at the first ventilatory threshold (VT1) at 2 months
Variation of oxygen (VO2) (ml/min/kg) at the first ventilatory threshold (VT1) during a cardio-pulmonary exercise test (CPET) before and after 15 training sessions performed
Months: 0, 2
Secondary Outcomes (9)
oxygen (VO2) peak
Months: 0, 2
maximum power workload
Months: 0, 2
power at the first ventilatory threshold (VT1)
Months: 0, 2
maximum heart rate
Months: 0, 2
recovery heart rate
Months: 0, 2
- +4 more secondary outcomes
Study Arms (2)
Home-based cardiac telerehabilitation (interventional group)
Patients followed the cardiac rehabilitation program at home.
Traditional centre-based cardiac rehabilitation (control group)
Patients participates in the cardiac rehabilitation program in hospital.
Interventions
* A video conference interview with an Adapted Physical Activity (APA) teacher before starting physical training * Exercise training for 3 weeks via distance coaching * Therapeutic patient education (TPE) workshops conducted remotely with 1 workshop per week. * Medical follow-up via teleconsultation * Psychological and/or dietetic follow-up if necessary. * Final assessment at 1 month with evaluation of aerobic metabolism, functional evaluation and final shared educational assessment (BEP). * Appointment with an association "Cœur et Santé" and "Sport-Santé 42" or setting up of an individual physical activity
Eligibility Criteria
Patient Acute Coronary Syndrome treated in the last 6 months will be included.
You may qualify if:
- Both groups:
- Acute Coronary Syndrome treated in the last 6 months
- Medical revascularization (angioplasty ± stenting) or surgical (coronary artery bypass)
- For Telerehabilitation group:
- Internet connexion (computer or digital tablet)
- Equipped with an exercise bike
You may not qualify if:
- Both groups:
- Pulmonary hypertension
- Aortic pathway anomaly
- Uncontrolled ventricular rhythm disorders
- For Telerehabilitation group:
- Important muscular deconditioning
- Patient requiring medical supervision in institute
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Saint-Etienne
Saint-Etienne, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Hupin, MD
CHU SAINT-ETIENNE
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2023
First Posted
March 1, 2023
Study Start
March 1, 2021
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
March 3, 2023
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share